IDHC Stock Overview
Operates as a consumer healthcare company that provides medical diagnostics services to patients. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 6/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Integrated Diagnostics Holdings plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.35 |
| 52 Week High | US$0.54 |
| 52 Week Low | US$0.28 |
| Beta | 0.26 |
| 1 Month Change | 2.05% |
| 3 Month Change | -4.13% |
| 1 Year Change | 6.10% |
| 3 Year Change | -67.48% |
| 5 Year Change | -59.59% |
| Change since IPO | -75.14% |
Recent News & Updates
Recent updates
Egypt Branch Expansions And Saudi Operations Will Drive Future Success
Apr 06 Strategic expansions and price adjustments in core markets like Egypt and Saudi Arabia are driving revenue and supporting net margin growth.Integrated Diagnostics Holdings (LON:IDHC) Will Be Hoping To Turn Its Returns On Capital Around
Nov 07
Is Integrated Diagnostics Holdings (LON:IDHC) A Risky Investment?
Oct 17Returns On Capital Signal Tricky Times Ahead For Integrated Diagnostics Holdings (LON:IDHC)
Jun 22Integrated Diagnostics Holdings' (LON:IDHC) Problems Go Beyond Weak Profit
Nov 25Does Integrated Diagnostics Holdings (LON:IDHC) Have A Healthy Balance Sheet?
Sep 06Shareholder Returns
| IDHC | GB Healthcare | GB Market | |
|---|---|---|---|
| 7D | -1.1% | 1.2% | -0.3% |
| 1Y | 6.1% | -2.4% | -0.7% |
Return vs Industry: IDHC exceeded the UK Healthcare industry which returned -2.4% over the past year.
Return vs Market: IDHC exceeded the UK Market which returned -0.7% over the past year.
Price Volatility
| IDHC volatility | |
|---|---|
| IDHC Average Weekly Movement | 8.1% |
| Healthcare Industry Average Movement | 6.9% |
| Market Average Movement | 5.8% |
| 10% most volatile stocks in GB Market | 11.0% |
| 10% least volatile stocks in GB Market | 3.2% |
Stable Share Price: IDHC's share price has been volatile over the past 3 months compared to the UK market.
Volatility Over Time: IDHC's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of UK stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 6,309 | Hend El Sherbini | www.idhcorp.com |
Integrated Diagnostics Holdings plc operates as a consumer healthcare company that provides medical diagnostics services to patients. It offers approximately 3,000 diagnostic pathology tests, such as immunology, microbiology, haematology, endocrinology, clinical chemistry, molecular biology, parasitology, histopathology, and genetics. The company also provides radiology services, such as positron emission tomography - computed tomography (PET-CT), MRI, computed tomography (CT), mammography, ultrasound, X-Ray, electromyography, electroencephalography, electroencephalogram, and electrocardiogram, as well as operates cath lab facilities.
Integrated Diagnostics Holdings plc Fundamentals Summary
| IDHC fundamental statistics | |
|---|---|
| Market cap | US$202.30m |
| Earnings (TTM) | US$21.29m |
| Revenue (TTM) | US$113.01m |
9.5x
P/E Ratio1.8x
P/S RatioIs IDHC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IDHC income statement (TTM) | |
|---|---|
| Revenue | ج.م5.72b |
| Cost of Revenue | ج.م3.54b |
| Gross Profit | ج.م2.18b |
| Other Expenses | ج.م1.10b |
| Earnings | ج.م1.08b |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.85 |
| Gross Margin | 38.14% |
| Net Profit Margin | 18.84% |
| Debt/Equity Ratio | 7.6% |
How did IDHC perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/11 10:08 |
| End of Day Share Price | 2025/05/09 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Integrated Diagnostics Holdings plc is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Marc Hammoud | Deutsche Bank |
| Ahmed Moataz | EFG-Hermes Research |
| Raj Sinha | HSBC |